Clinical Trial

Atrial Fibrillation Clinical Trial 20203031

[LCID Study Number: 20203031]

A Multi-center, Prospective, Single Arm Post Market Registry to Evaluate Procedural Outcomes Data Using the Cardiva Vascade MVP Venous Vascular Closure System (VVCS) for the Management of the Femoral Venotomy After Catheter-based Paroxysmal Atrial Fibrillation Interventions With or Without Another Arrhythmia, Performed via 6-12FR Procedural Sheaths With Single or Multiple Access Sites per Limb for Patients Who are Discharged the Same Day

The purpose of this registry is to collect procedural outcomes data when same day discharge is enabled by the Cardiva Vascade MVP Venous Vascular Closure System (VVCS) device.

Disease/Condition: Atrial Fibrillation

Department: Cardiovascular Medicine

Status: Active, Not Recruiting

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email:

Primary Contact Phone: 781-744-2734

Clinical Trial Detalis

Protocol #: 20203031

Study Coordinator(s): Deborah Gannon